Clinical review: The role of advanced glycation end products in progression and complications of diabetes.
about
Fisetin lowers methylglyoxal dependent protein glycation and limits the complications of diabetesVitamin B and its derivatives for diabetic kidney diseaseVitamin B and/or its derivatives for diabetic kidney diseaseAdvanced glycation end-products induce calpain-mediated degradation of ezrinThe Rationale for Insulin Therapy in Alzheimer's DiseaseHeavy Metals, Cardiovascular Disease, and the Unexpected Benefits of Chelation TherapyCurrent perspectives on the health risks associated with the consumption of advanced glycation end products: recommendations for dietary managementThe role of aflibercept in the management of diabetic macular edemaAloesin as a medical food ingredient for systemic oxidative stress of diabetesRole of T cells in type 2 diabetic nephropathyMetabolic correction in the management of diabetic peripheral neuropathy: improving clinical results beyond symptom controlDiabetic nephropathy and extracellular matrixBiomarkers in diabetes: hemoglobin A1c, vascular and tissue markersThe proteomics of drusenCrystal structure of the deglycating enzyme Amadoriase I in its free form and substrate-bound complexAdvanced Glycation End Products, Diabetes, and Bone StrengthEffect of isolated hyperglycemia on native mechanical and biologic shoulder joint properties in a rat modelComparison of In-Vitro and Ex-Vivo Wound Healing Assays for the Investigation of Diabetic Wound Healing and Demonstration of a Beneficial Effect of a Triterpene ExtractMetabolism of AGEs--bacterial AGEs are degraded by metallo-proteasesDFT study of the mechanism of the reaction of aminoguanidine with methylglyoxalDiabetic Polyneuropathy in Type 2 Diabetes Mellitus: Inflammation, Oxidative Stress, and Mitochondrial Function.Impaired Chaperone Activity of Human Heat Shock Protein Hsp27 Site-Specifically Modified with Argpyrimidine.Global Proteomic Analysis of Advanced Glycation End Products in the Arabidopsis Proteome Provides Evidence for Age-related Glycation Hotspots.Diabetic conditions promote binding of monocytes to vascular smooth muscle cells and their subsequent differentiationSerum carboxymethyl-lysine, disability, and frailty in older persons: the Cardiovascular Health Study.Molten globule of hemoglobin proceeds into aggregates and advanced glycated end products.Dietary Metabolites and Chronic Kidney Disease.Tailoring treatment to the individual in type 2 diabetes practical guidance from the Global Partnership for Effective Diabetes Management.Predicting Type 1 Diabetes Candidate Genes using Human Protein-Protein Interaction Networks.The succinated proteome.Diabetes-induced alterations in the extracellular matrix and their impact on myocardial function.Factors associated with topographic changes of the optic nerve head induced by acute intraocular pressure reduction in glaucoma patientsAbnormal amyloid β42 expression and increased oxidative stress in plasma of CKD patients with cognitive dysfunction: A small scale case control study comparison with Alzheimer's disease.Modulation of diabetic retinopathy pathophysiology by natural medicines through PPAR-γ-related pharmacology.The effect of an EDTA-based chelation regimen on patients with diabetes mellitus and prior myocardial infarction in the Trial to Assess Chelation Therapy (TACT)Mesenteric resistance arteries in type 2 diabetic db/db mice undergo outward remodeling.Glycation of wood frog (Rana sylvatica) hemoglobin and blood proteins: in vivo and in vitro studies.Type 2 diabetes is associated with altered NF-κB DNA binding activity, JNK phosphorylation, and AMPK phosphorylation in skeletal muscle after LPS.Chelation therapy after the trial to assess chelation therapy: results of a unique trial.Dietary advanced glycation end products are associated with decline in memory in young elderly.
P2860
Q21560804-C96022F7-CFCF-48CC-9D41-881CB22B537DQ24186641-7C5CB65D-BE66-432C-A019-0793E1CE73DBQ24236375-C0CA514F-11DF-481C-A95B-063790877413Q24293645-D0F6352E-4632-4668-B2C5-0170999F90F0Q26744834-9DC908AE-BDD6-45BE-BB90-78C85EA5BA13Q26747605-719081BC-8889-4258-8A61-58CC85A6B8D3Q26781156-92AD92B0-3199-4597-AF64-480F83230560Q26798348-8493D0AC-D344-4BDC-A993-6D480870F470Q26798991-C4D90A59-500F-4DAC-BE8F-828E60F1C3E4Q26849691-6593EFDE-7272-4E2A-95BE-29C145EB9630Q26852079-A670BD4B-5FC6-48C7-961C-AF5C45EF6ECAQ26996008-EFBF9508-E588-46C2-AC4B-7B164126815BQ26996480-79E1579D-79AA-49B6-9428-00C24BA5BE6AQ26997523-BC31581A-7EAF-4A90-8490-4DC34FB446DFQ27704012-13FA2A23-6C65-4F0F-A1A3-DE09F0FD92F5Q28076977-C7CC5C60-6215-485D-9CF6-8C2F354B37F9Q28392350-6B1EF26D-C2A5-407D-B9D7-90F6A46C38A9Q28468459-B476C60A-E7C0-4BCA-B82D-0D1303C04744Q28534296-4C2CC760-8868-42D7-9ECE-7E1801A5AD89Q30013723-49EC484D-D9F2-4248-81F0-036BAF475B2BQ30239828-F59F3C65-72CF-4401-BC92-942CA40FF600Q30390809-898624FA-00F2-43F9-9AA5-A5E2CEB4BC7EQ30403010-749B4A4A-C0EF-447B-BFDF-91765CC885A4Q30433016-14AD6415-450A-4D1A-8F54-EAD6E3213A93Q30578167-62F0CFBB-493C-4349-A963-DABA8EB112F3Q31132290-521EF05F-E6F6-46A4-B4E6-50E11B7EA2EAQ33616732-6EEFA512-1C46-477C-AB12-930C38F28D2BQ33621591-50F76732-B406-4355-BCCE-E1278D0D0243Q33636070-9E03D9A6-08F2-4278-9565-647F1E5BECB7Q33684446-BB93BE0A-9B51-4DF6-9DAD-EB9EF026490AQ33711031-3522EE27-078D-4EC4-B7B5-98E0565F30AFQ33762084-88305DCC-F3C8-4B7A-A1F3-6786B4024D42Q33854028-F268F7AC-EC6C-4F04-B637-46F8273E9462Q33867982-3E9889B1-0DDC-42F9-A4E4-3B8DDC1C970CQ33952145-80FF981A-A529-4FBC-A2B7-55B397BAC14CQ33988848-A14C5FD8-669C-461C-852F-CA9D6677EAEDQ34000386-7D86B28C-E660-4016-B410-A0BF640F691DQ34023225-FFEE1B2D-4A61-4A9C-808C-5F9FEF2F47C1Q34171149-33F6C0B2-8B1D-4237-A3EC-5F90658A0FAAQ34204074-9B42CB40-6BFC-4CF8-B0E4-2152EA885CF6
P2860
Clinical review: The role of advanced glycation end products in progression and complications of diabetes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical review: The role of a ...... and complications of diabetes.
@en
Clinical review: The role of a ...... and complications of diabetes.
@nl
type
label
Clinical review: The role of a ...... and complications of diabetes.
@en
Clinical review: The role of a ...... and complications of diabetes.
@nl
prefLabel
Clinical review: The role of a ...... and complications of diabetes.
@en
Clinical review: The role of a ...... and complications of diabetes.
@nl
P356
P1476
Clinical review: The role of a ...... and complications of diabetes.
@en
P2093
Mark E Cooper
Su-Yen Goh
P304
P356
10.1210/JC.2007-1817
P407
P577
2008-01-08T00:00:00Z